Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M116,725Revenue $M20,063Net Margin (%)27.7Altman Z-Score2.7
Enterprise Value $M119,948EPS $6.7Operating Margin %33.3Piotroski F-Score5
P/E(ttm)20.7Beneish M-Score-2.7Pre-tax Margin (%)30.4Higher ROA y-yN
Price/Book4.410-y EBITDA Growth Rate %11.2Quick Ratio5.1Cash flow > EarningsY
Price/Sales5.75-y EBITDA Growth Rate %10.4Current Ratio5.5Lower Leverage y-yY
Price/Free Cash Flow15.2y-y EBITDA Growth Rate %21.8ROA % (ttm)8.3Higher Current Ratio y-yY
Dividend Yield %1.8PEG2.0ROE % (ttm)22.9Less Shares Outstanding y-yN
Payout Ratio %35.0Shares Outstanding M760ROIC % (ttm)20.1Gross Margin Increase y-yN

Gurus Latest Trades with AMGN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AMGNJoel Greenblatt 2015-03-31 Add0.37%$150.01 - $170.1
($157.49)
$ 153.26-3%Add 2874.44%309,134
AMGNFirst Eagle Investment 2015-03-31 Reduce-0.06%$150.01 - $170.1
($157.49)
$ 153.26-3%Reduce 23.66%497,622
AMGNDodge & Cox 2015-03-31 Reduce$150.01 - $170.1
($157.49)
$ 153.26-3%Reduce 17.65%54,704
AMGNMario Gabelli 2015-03-31 Add$150.01 - $170.1
($157.49)
$ 153.26-3%Add 1.23%39,985
AMGNKen Fisher 2015-03-31 Add$150.01 - $170.1
($157.49)
$ 153.26-3%Add 1.41%156,623
AMGNVanguard Health Care Fund 2014-12-31 Reduce-0.51%$130.45 - $171.64
($155.84)
$ 153.26-2%Reduce 20.54%5,580,485
AMGNMario Gabelli 2014-12-31 Reduce-0.02%$130.45 - $171.64
($155.84)
$ 153.26-2%Reduce 34.11%39,500
AMGNJoel Greenblatt 2014-12-31 Add0.01%$130.45 - $171.64
($156.25)
$ 153.26-2%Add 285.93%10,393
AMGNVanguard Health Care Fund 2014-09-30 Reduce-0.32%$115.39 - $144.01
($130.57)
$ 153.2617%Reduce 12.75%7,022,755
AMGNFirst Eagle Investment 2014-09-30 Buy 0.25%$115.39 - $144.01
($130.57)
$ 153.2617%New holding714,178
AMGNKen Fisher 2014-09-30 Add0.02%$115.39 - $144.01
($130.57)
$ 153.2617%Add 83.59%156,629
AMGNJoel Greenblatt 2014-09-30 Reduce-0.01%$115.39 - $144.01
($130.57)
$ 153.2617%Reduce 72.90%2,693
AMGNRuane Cunniff 2014-09-30 Buy $115.39 - $144.01
($130.57)
$ 153.2617%New holding1,617
AMGNVanguard Health Care Fund 2014-06-30 Reduce-0.06%$110.29 - $126.07
($115.88)
$ 153.2632%Reduce 2.00%8,049,455
AMGNMario Gabelli 2014-06-30 Add0.02%$110.29 - $126.07
($115.72)
$ 153.2632%Add 85.28%60,335
AMGNJoel Greenblatt 2014-06-30 Buy 0.02%$110.29 - $126.07
($115.72)
$ 153.2632%New holding9,938
AMGNKen Fisher 2014-06-30 Add0.01%$110.29 - $126.07
($115.72)
$ 153.2632%Add 71.02%85,316
AMGNDodge & Cox 2014-06-30 Reduce$110.29 - $126.07
($115.88)
$ 153.2632%Reduce 18.82%85,857
AMGNVanguard Health Care Fund 2014-03-31 Reduce-0.2%$113.48 - $127.47
($120.95)
$ 153.2627%Reduce 6.40%8,213,855
AMGNJoel Greenblatt 2014-03-31 Sold Out -0.06%$113.48 - $127.47
($121.04)
$ 153.2627%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AMGN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


AMGN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Patton Cynthia MSVP & CCO 2015-06-02Sell4,530$157.06-2.42view
Balachandran MadhavanEVP, Operations 2015-05-07Sell21,750$157.87-2.92view
Tross Stuart ASVP, Human Resources 2015-04-23Sell3,012$169.31-9.48view
Harper Sean EEVP, Research & Development 2015-04-22Sell28,000$171.58-10.68view
Tross Stuart ASVP, Human Resources 2015-03-03Sell4,415$157.74-2.84view
BALTIMORE DAVIDDirector 2015-03-02Sell3,647$158.76-3.46view
Bradway Robert AChairman, CEO and President 2015-02-11Sell22,000$152.690.37view
HERRINGER FRANK CDirector 2015-02-05Buy3,000$152.290.64view
de Carbonnel FrancoisDirector 2014-12-03Sell3,000$168.01-8.78view
Harper Sean EEVP, Research & Development 2014-08-05Sell14,000$127.2920.4view

Press Releases about AMGN :

Quarterly/Annual Reports about AMGN:

News about AMGN:

Articles On GuruFocus.com
Activist Hedge Fund Manager Has Strong Focus on Health Care Stocks Jun 11 2015 
PRIMECAP Sells Portions of Its Top Two Stakes May 27 2015 
Amgen And AstraZeneca’s Deal On Psoriasis Drug Faces Termination May 27 2015 
Amgen’s Cholesterol Fighting Drug Receives EU Approval May 26 2015 
Crouching Tigers, Hidden Assets – Smead Capital Management Apr 30 2015 
securities Apr 27 2015 
Amgen Reports An Upbeat Q1 Earnings Apr 23 2015 
Amgen Inc.’s First Quarter Earnings Preview – What Could Be In Store? Apr 20 2015 
Amgen’s First Drug For Cardiovascular Disease Gets The Green Light Apr 17 2015 
Vanguard Health Care Fund Comments on Amgen Inc Mar 27 2015 

More From Other Websites
Why is Celgene So Darn Expensive? Jun 30 2015
Citigroup Still Says Sell AbbVie Jun 30 2015
Is Celgene's Juno Deal a Boon or a Boondoggle? Jun 30 2015
Evercore ISI Analyst Breaks Down Amgen's IPR Against AbbVie's Humira Formulation Patent Jun 29 2015
Biotech Short-Sellers Prefer Amgen To Gilead Sciences Jun 27 2015
Five Best Stocks to Buy According To Quant Billionaires Jun 25 2015
The Zacks Analyst Blog Highlights: BioMarin, Vical, Epizyme, Amgen and Medicines Co - Press Releases Jun 25 2015
Biotech Stock Roundup: BioMarin Jumps on Dwarfism Data, Vical Plunges on Vaccine Data - Analyst Blog Jun 24 2015
Inside Kite Pharma's 100% run Jun 24 2015
Amgen Dazzles With a Duo of Fresh Data Jun 23 2015
Amgen Presents Interim Data on Migraine Drug AMG 334 - Analyst Blog Jun 22 2015
Celimmune to Present Experimental Anti-IL-15 Antibody AMG 714 at 16th International Coeliac Disease... Jun 22 2015
Amgen Presents Open-Label Extension Data From Ongoing Phase 2 Study Of AMG 334 In The Prevention Of... Jun 19 2015
Amgen Cancer Drug Vectibix Hits Phase III Primary Endpoint - Analyst Blog Jun 19 2015
Amgen Presents Open-Label Extension Data From Ongoing Phase 2 Study Of AMG 334 In The Prevention Of... Jun 19 2015
Biotech bargain bin Jun 19 2015
Why Biogen Is Inches Away From Changing the World Jun 19 2015
Biotechs about to break out: Pro Jun 19 2015
Healthcare heats up in the summer Jun 19 2015
Early movers: HSY, RHT, SWHC, STT, CAG & more Jun 19 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK